Back to Search
Start Over
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: Results from the Italian Severe Asthma Registry.
- Source :
- Allergy; Mar2021, Vol. 76 Issue 3, p902-905, 4p
- Publication Year :
- 2021
-
Abstract
- Asthma, asthma treatment, biologics, infections, virus Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: Results from the Italian Severe Asthma Registry Keywords: asthma; asthma treatment; biologics; infections; virus EN asthma asthma treatment biologics infections virus 902 905 4 03/09/21 20210301 NES 210301 To the Editor, Severe asthma is a chronic disease affecting around 3%-8% of adult asthma population in Europe, with the refractory form estimated to occur in 0.1% of the general population.1,2 Severe asthma is characterized by increased use of healthcare resources (ie, emergency room/hospital admissions, access to intensive care units (ICU), and use of biologics) due to exacerbations compared with the less severe form. [Extracted from the article]
- Subjects :
- COVID-19
ASTHMA
COVID-19 pandemic
Subjects
Details
- Language :
- English
- ISSN :
- 01054538
- Volume :
- 76
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Allergy
- Publication Type :
- Academic Journal
- Accession number :
- 149107374
- Full Text :
- https://doi.org/10.1111/all.14558